View ValuationOrica 향후 성장Future 기준 점검 3/6Orica (는) 각각 연간 28.1% 및 2.9% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 23.1% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 15.8% 로 예상됩니다.핵심 정보28.1%이익 성장률23.08%EPS 성장률Chemicals 이익 성장43.1%매출 성장률2.9%향후 자기자본이익률15.81%애널리스트 커버리지Good마지막 업데이트07 May 2026최근 향후 성장 업데이트공지 • Nov 11+ 1 more updateOrica Limited Provides Earnings Guidance for the Year 2024Orica Limited provided earnings guidance for the year 2024. The company’s 2024 financial year EBIT from continuing operations is expected to increase.모든 업데이트 보기Recent updates공지 • Jan 05+ 2 more updatesOrica Limited, Annual General Meeting, Dec 16, 2026Orica Limited, Annual General Meeting, Dec 16, 2026.공지 • Jul 09Orica Limited Appoints Vik Bansal as Non-Executive Director and Chair ElectOrica Limited Chair, Malcolm Broomhead, announced the appointment of Vik Bansal to the Orica Limited Board as a Non-Executive Director, effective August 15, 2025. The Board has elected Mr. Bansal as Chair Elect, to assume the role at the completion of the 2025 Annual General Meeting. Vik Bansal is an experienced executive and non-executive director with over 30 years of experience managing complex industrial organisations. He is currently a non-executive director of Brambles Ltd. and Chair of LGI Limited, a clean energy company. Vik has held significant leadership roles in various industries where he led strategic growth and performance improvements, including CEO positions at Boral, InfraBuild, and Cleanaway, and global leadership roles at NYSE-listed Valmont Industries. Throughout his career, Vik has been recognised for his ability to drive shareholder returns through strategic and operational improvements. He has served on the boards of several organisations, including the National Waste & Recycling Industry Council and the Waste Management and Resource Recovery Association of Australia and not-for-profit Disability Services Australia. Vik is a Fellow of the Institute of Engineers Australia and the Australian Institute of Company Directors. Vik holds an Electrical Engineering degree with First Class Honors from NIT - Kurukshetra, an MBA from Deakin University, an Advanced Management Program from INSEAD, and a Master of Laws in Enterprise Governance.공지 • Mar 12Orica Limited (ASX:ORI) announces an Equity Buyback for AUD 400 million worth of its shares.Orica Limited (ASX:ORI) announces a share repurchase program. Under the program, the company will repurchase up to AUD 400 million worth of its shares. The program will be valid till March 27, 2026. As of March 12, 2025, the company had 487,360,505 issued shares.공지 • Jan 31Orica Limited Announces Executive ChangesOrica Limited announced that Erin O'Connor and Kirsten Anderson Llewellyn have each resigned as Company Secretary effective 31 January 2025. Krista Stewart has been appointed as Group General Counsel and Company Secretary, effective 31 January 2025, and will be the person responsible for communication with the ASX under Listing Rule 12.6.공지 • Jan 13+ 2 more updatesOrica Limited, Annual General Meeting, Dec 16, 2025Orica Limited, Annual General Meeting, Dec 16, 2025.Declared Dividend • Nov 17Final dividend of AU$0.28 announcedShareholders will receive a dividend of AU$0.28. Ex-date: 22nd November 2024 Payment date: 23rd December 2024 Dividend yield will be 3.6%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is covered by both earnings (42% earnings payout ratio) and cash flows (65% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 26% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Reported Earnings • Nov 16Full year 2024 earnings released: EPS: AU$1.11 (vs AU$0.65 in FY 2023)Full year 2024 results: EPS: AU$1.11 (up from AU$0.65 in FY 2023). Revenue: AU$7.66b (down 3.6% from FY 2023). Net income: AU$524.6m (up 77% from FY 2023). Profit margin: 6.8% (up from 3.7% in FY 2023). Revenue is forecast to grow 4.5% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 87% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.Declared Dividend • May 12First half dividend of AU$0.19 announcedShareholders will receive a dividend of AU$0.19. Ex-date: 23rd May 2024 Payment date: 3rd July 2024 Dividend yield will be 3.1%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is well covered by both earnings (39% earnings payout ratio) and cash flows (36% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 25% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Reported Earnings • May 10First half 2024 earnings released: EPS: AU$0.73 (vs AU$0.27 in 1H 2023)First half 2024 results: EPS: AU$0.73 (up from AU$0.27 in 1H 2023). Revenue: AU$3.66b (down 8.5% from 1H 2023). Net income: AU$337.5m (up 175% from 1H 2023). Profit margin: 9.2% (up from 3.1% in 1H 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 5.5% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.공지 • Feb 29Orica Limited Announces Retirement of Gene Tilbrook from the Board of DirectorsAs announced by Orica Chairman Malcolm Broomhead at the 2023 Annual General Meeting Mr. Gene Tilbrook has retired from the Board of Directors of Orica Limited, effective 29 February, 2024.New Risk • Feb 27New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 6.1% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Shareholders have been diluted in the past year (6.1% increase in shares outstanding).공지 • Feb 23Orica Limited has completed a Follow-on Equity Offering in the amount of AUD 400.000012 million.Orica Limited has completed a Follow-on Equity Offering in the amount of AUD 400.000012 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 25,252,526 Price\Range: AUD 15.84 Discount Per Security: AUD 0.2376 Transaction Features: Subsequent Direct Listing공지 • Feb 22+ 2 more updatesOrica Limited (ASX:ORI) entered into a binding agreement to acquire Cyanco Corporation from Cerberus Capital Management, L.P for the enterprise value of approximately $640 million.Orica Limited (ASX:ORI) entered into a binding agreement to acquire Cyanco Corporation from Cerberus Capital Management, L.P. for the enterprise value of approximately $640 million on February 21, 2024. The transaction will be financed with withdrawal from existing facility, balance sheet and institutional placement amount totaled $262.4 million. As of February 21, 2024, Cyanco reported the Net debt of approximately $665.3 million, total assets of approximately $545.2 million and EBITDA of $85 million. The acquisition is subject to the expiration of certain regulatory waiting periods and other customary closing conditions. The acquisition is expected to close by the end of FY2024. Morgan Stanley (NYSE:MS) acted as financial advisor to Cyanco Corporation.공지 • Jan 08+ 2 more updatesOrica Limited to Report First Half, 2024 Results on May 09, 2024Orica Limited announced that they will report first half, 2024 results on May 09, 2024공지 • Nov 11+ 1 more updateOrica Limited Provides Earnings Guidance for the Year 2024Orica Limited provided earnings guidance for the year 2024. The company’s 2024 financial year EBIT from continuing operations is expected to increase.Reported Earnings • Nov 09Full year 2023 earnings released: EPS: AU$0.65 (vs AU$0.35 in FY 2022)Full year 2023 results: EPS: AU$0.65 (up from AU$0.35 in FY 2022). Revenue: AU$7.95b (up 12% from FY 2022). Net income: AU$295.7m (up 104% from FY 2022). Profit margin: 3.7% (up from 2.0% in FY 2022). Revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.공지 • Nov 02CF Industries Files a Separate Lawsuit in the United States Against OricaOrica announced that it is a joint plaintiff in a lawsuit filed in the United States on 21 October 2023 (US time) against CF Industries regarding contractual disputes under an ammonium nitrate purchase agreement for the supply of ammonium nitrate and related products for use by Orica's business across North America. CF Industries filed a separate lawsuit in the United States regarding contractual disputes of this agreement on 22 October 2023 (US time). Orica is pursuing its claims and defending CF Industries' claims while continuing to fully comply with its contractual obligations.Upcoming Dividend • May 18Upcoming dividend of AU$0.18 per share at 2.2% yieldEligible shareholders must have bought the stock before 25 May 2023. Payment date: 03 July 2023. Payout ratio is a comfortable 65% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (5.7%).공지 • May 13Orica Limited Announces Distribution for the Six Months Ended March 31, 2023, Payable on July 3, 2023Orica Limited announced the Distribution of AUD 0.18000000 per share for the six months ended March 31, 2023, payable on July 3, 2023. Record Date is on May 26, 2023 and Ex date is on May 25, 2023.Reported Earnings • May 11First half 2023 earnings releasedFirst half 2023 results: EPS: AU$0.27. Revenue: AU$4.01b (up 31% from 1H 2022). Net income: AU$122.6m (up AU$122.6m from 1H 2022). Profit margin: 3.1% (up from 0% in 1H 2022). Revenue is forecast to stay flat during the next 3 years compared to a 3.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.공지 • Jan 18Orica Limited Announces Vanessa Guthrie AO as Independent, Non-Executive, Effective 1 February 2023Orica Limited announced the appointment of Dr. Vanessa Guthrie AO as independent, Non-Executive Director, to the Orica Board effective 1 February 2023. The appointment of Dr. Guthrie is part of the Orica Board's ongoing renewal process, following the retirement of Ms. Maxine Brenner and Mr. Boon Swan Foo at the conclusion of the 2022 Annual General Meeting and the previously announced appointment of Mr. Mark Garrett, effective 15 January 2023. Dr. Guthrie's broad and strategic experience in the resources sector started over 30 years ago in Australia with RGC Limited (Tasmania). Since then, Dr.Guthrie has held a diverse set of senior leadership roles across operations, environment, community, indigenous affairs and corporate development and sustainability. Previously Managing Director and CEO of ASX-listed Toro Energy Limited and private company Wellard Enterprises, Vice President Sustainable Development of Woodside Energy Limited, Huntly Mine Manager of Alcoa Australia and Chair of Minerals Council of Australia. Dr. Guthrie is Deputy Chair and Lead Independent Director of Adbri Limited, Non-Executive Director of Santos Limited, Tronox Holdings PLC and Lynas Rare Earths Limited, Non-Executive Director of Cricket Australia and Infrastructure Australia, and Pro-Chancellor of Curtin University. Dr. Guthrie's contribution to the mining and resources industry was recognised in 2017 with the award of an Honorary Doctor of Science from Curtin University. In 2021 she was also made an Officer of the Order of Australia. Dr. Guthrie is also a Fellow of the Australian Institute of Company Directors (FAICD), the Australian Academy of Technological Sciences and Engineering (FTSE) and the Australasian Institute of Mining and Metallurgy (FAusIMM). Dr. Guthrie has qualifications in geology, environment, law and business management, including a PhD in Geology.공지 • Dec 23+ 2 more updatesOrica Limited, Annual General Meeting, Feb 13, 2023Orica Limited, Annual General Meeting, Feb 13, 2023.Reported Earnings • Nov 10Full year 2022 earnings released: EPS: AU$0.35 (vs AU$0.46 loss in FY 2021)Full year 2022 results: EPS: AU$0.35 (up from AU$0.46 loss in FY 2021). Revenue: AU$7.14b (up 36% from FY 2021). Net income: AU$144.7m (up AU$333.1m from FY 2021). Profit margin: 2.0% (up from net loss in FY 2021). Revenue is forecast to grow 2.3% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to remain flat. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 74 percentage points per year, which is a significant difference in performance.Upcoming Dividend • May 24Upcoming dividend of AU$0.13 per shareEligible shareholders must have bought the stock before 31 May 2022. Payment date: 08 July 2022. The company is not currently making a profit and is not cash flow positive. Trailing yield: 1.5%. Lower than top quartile of German dividend payers (4.2%). Lower than average of industry peers (5.1%).Reported Earnings • May 13First half 2022 earnings releasedFirst half 2022 results: Revenue: (down 100% from 1H 2021). Net income: (down AU$76.7m from profit in 1H 2021). Profit margin: (down from 2.9% in 1H 2021). Over the next year, revenue is forecast to grow 7.4%, compared to a 6.4% growth forecast for the industry in Germany.Recent Insider Transactions • Nov 17Independent Non-Executive Director recently bought €161k worth of stockOn the 15th of November, Boon Foo bought around 16k shares on-market at roughly €10.06 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €380k more in shares than they have sold in the last 12 months.Reported Earnings • Nov 12Full year 2021 earnings releasedThe company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2021 results: Revenue: AU$5.25b (down 6.7% from FY 2020). Net loss: AU$188.4m (down 212% from profit in FY 2020).Valuation Update With 7 Day Price Move • Oct 02Investor sentiment improved over the past weekAfter last week's 17% share price gain to €8.75, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 11x in the Chemicals industry in Germany. Total loss to shareholders of 8.9% over the past three years.Recent Insider Transactions • Oct 02Independent Non-Executive Director recently bought €85k worth of stockOn the 30th of September, Denise Gibson bought around 10k shares on-market at roughly €8.55 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €219k more in shares than they have sold in the last 12 months.Upcoming Dividend • May 24Upcoming dividend of AU$0.075 per shareEligible shareholders must have bought the stock before 31 May 2021. Payment date: 09 July 2021. Trailing yield: 1.8%. Lower than top quartile of German dividend payers (3.2%). Lower than average of industry peers (3.6%).Reported Earnings • May 14First half 2021 earnings released: EPS AU$0.19 (vs AU$0.43 in 1H 2020)The company reported a poor first half result with weaker earnings, revenues and profit margins. First half 2021 results: Revenue: AU$2.64b (down 8.7% from 1H 2020). Net income: AU$76.7m (down 54% from 1H 2020). Profit margin: 2.9% (down from 5.7% in 1H 2020). Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.Executive Departure • Apr 09MD, CEO & Executive Director Alberto Zuleta has left the companyOn the 1st of April, Alberto Zuleta, was replaced as CEO by Sanjeev Gandhi. As of December 2020, Alberto personally held 268.40k shares (€2.6m worth at the time). A total of 2 executives have left over the last 12 months.Valuation Update With 7 Day Price Move • Mar 02Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to AU$8.10, the stock is trading at a trailing P/E ratio of 29.4x, down from the previous P/E ratio of 35.7x. This compares to an average P/E of 23x in the Chemicals industry in Germany. Total return to shareholders over the past three years is a loss of 23%.Is New 90 Day High Low • Feb 28New 90-day low: €8.30The company is down 20% from its price of €10.40 on 27 November 2020. The German market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €16.52 per share.Recent Insider Transactions • Jan 14MD, CEO & Executive Director recently bought €83k worth of stockOn the 14th of January, Alberto Zuleta bought around 7k shares on-market at roughly €12.01 per share. This was the largest purchase by an insider in the last 3 months. Alberto has been a buyer over the last 12 months, purchasing a net total of €131k worth in shares.Reported Earnings • Nov 22Full year 2020 earnings released: EPS AU$0.42The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: AU$5.63b (down 4.5% from FY 2019). Net income: AU$168.3m (down 31% from FY 2019). Profit margin: 3.0% (down from 4.2% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Analyst Estimate Surprise Post Earnings • Nov 22Revenue misses expectationsRevenue missed analyst estimates by 1.0%. Over the next year, revenue is forecast to grow 2.9%, compared to a 3.7% growth forecast for the Chemicals industry in Germany.Is New 90 Day High Low • Nov 02New 90-day low: €9.05The company is down 12% from its price of €10.30 on 04 August 2020. The German market is down 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €17.54 per share.Is New 90 Day High Low • Sep 23New 90-day low: €9.45The company is down 4.0% from its price of €9.80 on 25 June 2020. The German market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €14.46 per share.이익 및 매출 성장 예측DB:ICA - 애널리스트 향후 추정치 및 과거 재무 데이터 (AUD Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수9/30/20288,7027028581,239139/30/20278,4676387481,109139/30/20268,163325440675123/31/20268,116251465935N/A12/31/20258,149207500942N/A9/30/20258,183162535949N/A6/30/20258,104130495906N/A3/31/20257,99998456862N/A12/31/20247,845311403835N/A9/30/20247,691525351808N/A6/30/20247,647518468948N/A3/31/20247,6045115851,088N/A12/31/20237,775403522993N/A9/30/20237,945296460899N/A6/30/20237,997282314710N/A3/31/20238,049267169521N/A12/31/20227,57320691441N/A9/30/20227,09614513362N/A3/31/20225,870-262-19323N/A12/31/20215,556-225138471N/A9/30/20215,242-188296619N/A3/31/20214,690-21-70176N/A12/31/20204,92625-158161N/A9/30/20205,16171-247145N/A6/30/20205,789273-44474N/A3/31/20205,948377158671N/A12/31/20195,922311N/A708N/A9/30/20195,896245N/A746N/A6/30/20195,794230N/A758N/A3/31/20195,691214N/A770N/A12/31/20185,54783N/A692N/A9/30/20185,402-48N/A615N/A6/30/20185,282-43N/A478N/A3/31/20185,162-38N/A340N/A12/31/20175,116174N/A403N/A9/30/20175,070386N/A466N/A6/30/20175,035388N/A633N/A3/31/20174,999389N/A800N/A12/31/20165,055366N/A789N/A9/30/20165,111343N/A778N/A3/31/20165,431-1,336N/A593N/A12/31/20155,552-1,306N/A666N/A9/30/20155,673-1,275N/A739N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: ICA 의 연간 예상 수익 증가율(28.1%)이 saving rate(1.9%)보다 높습니다.수익 vs 시장: ICA 의 연간 수익(28.1%)이 German 시장(16.9%)보다 빠르게 성장할 것으로 예상됩니다.고성장 수익: ICA 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.수익 대 시장: ICA 의 수익(연간 2.9%)이 German 시장(연간 6.5%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: ICA 의 수익(연간 2.9%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: ICA의 자본 수익률은 3년 후 15.8%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/07 12:40종가2026/05/07 00:00수익2026/03/31연간 수익2025/09/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Orica Limited는 33명의 분석가가 다루고 있습니다. 이 중 14명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Brook Campbell-CrawfordBarrenjoey Markets Pty LimitedBenjamin BrayshawBarrenjoey Markets Pty LimitedJoseph HouseBell Potter30명의 분석가 더 보기
공지 • Nov 11+ 1 more updateOrica Limited Provides Earnings Guidance for the Year 2024Orica Limited provided earnings guidance for the year 2024. The company’s 2024 financial year EBIT from continuing operations is expected to increase.
공지 • Jan 05+ 2 more updatesOrica Limited, Annual General Meeting, Dec 16, 2026Orica Limited, Annual General Meeting, Dec 16, 2026.
공지 • Jul 09Orica Limited Appoints Vik Bansal as Non-Executive Director and Chair ElectOrica Limited Chair, Malcolm Broomhead, announced the appointment of Vik Bansal to the Orica Limited Board as a Non-Executive Director, effective August 15, 2025. The Board has elected Mr. Bansal as Chair Elect, to assume the role at the completion of the 2025 Annual General Meeting. Vik Bansal is an experienced executive and non-executive director with over 30 years of experience managing complex industrial organisations. He is currently a non-executive director of Brambles Ltd. and Chair of LGI Limited, a clean energy company. Vik has held significant leadership roles in various industries where he led strategic growth and performance improvements, including CEO positions at Boral, InfraBuild, and Cleanaway, and global leadership roles at NYSE-listed Valmont Industries. Throughout his career, Vik has been recognised for his ability to drive shareholder returns through strategic and operational improvements. He has served on the boards of several organisations, including the National Waste & Recycling Industry Council and the Waste Management and Resource Recovery Association of Australia and not-for-profit Disability Services Australia. Vik is a Fellow of the Institute of Engineers Australia and the Australian Institute of Company Directors. Vik holds an Electrical Engineering degree with First Class Honors from NIT - Kurukshetra, an MBA from Deakin University, an Advanced Management Program from INSEAD, and a Master of Laws in Enterprise Governance.
공지 • Mar 12Orica Limited (ASX:ORI) announces an Equity Buyback for AUD 400 million worth of its shares.Orica Limited (ASX:ORI) announces a share repurchase program. Under the program, the company will repurchase up to AUD 400 million worth of its shares. The program will be valid till March 27, 2026. As of March 12, 2025, the company had 487,360,505 issued shares.
공지 • Jan 31Orica Limited Announces Executive ChangesOrica Limited announced that Erin O'Connor and Kirsten Anderson Llewellyn have each resigned as Company Secretary effective 31 January 2025. Krista Stewart has been appointed as Group General Counsel and Company Secretary, effective 31 January 2025, and will be the person responsible for communication with the ASX under Listing Rule 12.6.
공지 • Jan 13+ 2 more updatesOrica Limited, Annual General Meeting, Dec 16, 2025Orica Limited, Annual General Meeting, Dec 16, 2025.
Declared Dividend • Nov 17Final dividend of AU$0.28 announcedShareholders will receive a dividend of AU$0.28. Ex-date: 22nd November 2024 Payment date: 23rd December 2024 Dividend yield will be 3.6%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is covered by both earnings (42% earnings payout ratio) and cash flows (65% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 26% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Reported Earnings • Nov 16Full year 2024 earnings released: EPS: AU$1.11 (vs AU$0.65 in FY 2023)Full year 2024 results: EPS: AU$1.11 (up from AU$0.65 in FY 2023). Revenue: AU$7.66b (down 3.6% from FY 2023). Net income: AU$524.6m (up 77% from FY 2023). Profit margin: 6.8% (up from 3.7% in FY 2023). Revenue is forecast to grow 4.5% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 87% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
Declared Dividend • May 12First half dividend of AU$0.19 announcedShareholders will receive a dividend of AU$0.19. Ex-date: 23rd May 2024 Payment date: 3rd July 2024 Dividend yield will be 3.1%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is well covered by both earnings (39% earnings payout ratio) and cash flows (36% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 25% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Reported Earnings • May 10First half 2024 earnings released: EPS: AU$0.73 (vs AU$0.27 in 1H 2023)First half 2024 results: EPS: AU$0.73 (up from AU$0.27 in 1H 2023). Revenue: AU$3.66b (down 8.5% from 1H 2023). Net income: AU$337.5m (up 175% from 1H 2023). Profit margin: 9.2% (up from 3.1% in 1H 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 5.5% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.
공지 • Feb 29Orica Limited Announces Retirement of Gene Tilbrook from the Board of DirectorsAs announced by Orica Chairman Malcolm Broomhead at the 2023 Annual General Meeting Mr. Gene Tilbrook has retired from the Board of Directors of Orica Limited, effective 29 February, 2024.
New Risk • Feb 27New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 6.1% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Shareholders have been diluted in the past year (6.1% increase in shares outstanding).
공지 • Feb 23Orica Limited has completed a Follow-on Equity Offering in the amount of AUD 400.000012 million.Orica Limited has completed a Follow-on Equity Offering in the amount of AUD 400.000012 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 25,252,526 Price\Range: AUD 15.84 Discount Per Security: AUD 0.2376 Transaction Features: Subsequent Direct Listing
공지 • Feb 22+ 2 more updatesOrica Limited (ASX:ORI) entered into a binding agreement to acquire Cyanco Corporation from Cerberus Capital Management, L.P for the enterprise value of approximately $640 million.Orica Limited (ASX:ORI) entered into a binding agreement to acquire Cyanco Corporation from Cerberus Capital Management, L.P. for the enterprise value of approximately $640 million on February 21, 2024. The transaction will be financed with withdrawal from existing facility, balance sheet and institutional placement amount totaled $262.4 million. As of February 21, 2024, Cyanco reported the Net debt of approximately $665.3 million, total assets of approximately $545.2 million and EBITDA of $85 million. The acquisition is subject to the expiration of certain regulatory waiting periods and other customary closing conditions. The acquisition is expected to close by the end of FY2024. Morgan Stanley (NYSE:MS) acted as financial advisor to Cyanco Corporation.
공지 • Jan 08+ 2 more updatesOrica Limited to Report First Half, 2024 Results on May 09, 2024Orica Limited announced that they will report first half, 2024 results on May 09, 2024
공지 • Nov 11+ 1 more updateOrica Limited Provides Earnings Guidance for the Year 2024Orica Limited provided earnings guidance for the year 2024. The company’s 2024 financial year EBIT from continuing operations is expected to increase.
Reported Earnings • Nov 09Full year 2023 earnings released: EPS: AU$0.65 (vs AU$0.35 in FY 2022)Full year 2023 results: EPS: AU$0.65 (up from AU$0.35 in FY 2022). Revenue: AU$7.95b (up 12% from FY 2022). Net income: AU$295.7m (up 104% from FY 2022). Profit margin: 3.7% (up from 2.0% in FY 2022). Revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
공지 • Nov 02CF Industries Files a Separate Lawsuit in the United States Against OricaOrica announced that it is a joint plaintiff in a lawsuit filed in the United States on 21 October 2023 (US time) against CF Industries regarding contractual disputes under an ammonium nitrate purchase agreement for the supply of ammonium nitrate and related products for use by Orica's business across North America. CF Industries filed a separate lawsuit in the United States regarding contractual disputes of this agreement on 22 October 2023 (US time). Orica is pursuing its claims and defending CF Industries' claims while continuing to fully comply with its contractual obligations.
Upcoming Dividend • May 18Upcoming dividend of AU$0.18 per share at 2.2% yieldEligible shareholders must have bought the stock before 25 May 2023. Payment date: 03 July 2023. Payout ratio is a comfortable 65% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (5.7%).
공지 • May 13Orica Limited Announces Distribution for the Six Months Ended March 31, 2023, Payable on July 3, 2023Orica Limited announced the Distribution of AUD 0.18000000 per share for the six months ended March 31, 2023, payable on July 3, 2023. Record Date is on May 26, 2023 and Ex date is on May 25, 2023.
Reported Earnings • May 11First half 2023 earnings releasedFirst half 2023 results: EPS: AU$0.27. Revenue: AU$4.01b (up 31% from 1H 2022). Net income: AU$122.6m (up AU$122.6m from 1H 2022). Profit margin: 3.1% (up from 0% in 1H 2022). Revenue is forecast to stay flat during the next 3 years compared to a 3.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.
공지 • Jan 18Orica Limited Announces Vanessa Guthrie AO as Independent, Non-Executive, Effective 1 February 2023Orica Limited announced the appointment of Dr. Vanessa Guthrie AO as independent, Non-Executive Director, to the Orica Board effective 1 February 2023. The appointment of Dr. Guthrie is part of the Orica Board's ongoing renewal process, following the retirement of Ms. Maxine Brenner and Mr. Boon Swan Foo at the conclusion of the 2022 Annual General Meeting and the previously announced appointment of Mr. Mark Garrett, effective 15 January 2023. Dr. Guthrie's broad and strategic experience in the resources sector started over 30 years ago in Australia with RGC Limited (Tasmania). Since then, Dr.Guthrie has held a diverse set of senior leadership roles across operations, environment, community, indigenous affairs and corporate development and sustainability. Previously Managing Director and CEO of ASX-listed Toro Energy Limited and private company Wellard Enterprises, Vice President Sustainable Development of Woodside Energy Limited, Huntly Mine Manager of Alcoa Australia and Chair of Minerals Council of Australia. Dr. Guthrie is Deputy Chair and Lead Independent Director of Adbri Limited, Non-Executive Director of Santos Limited, Tronox Holdings PLC and Lynas Rare Earths Limited, Non-Executive Director of Cricket Australia and Infrastructure Australia, and Pro-Chancellor of Curtin University. Dr. Guthrie's contribution to the mining and resources industry was recognised in 2017 with the award of an Honorary Doctor of Science from Curtin University. In 2021 she was also made an Officer of the Order of Australia. Dr. Guthrie is also a Fellow of the Australian Institute of Company Directors (FAICD), the Australian Academy of Technological Sciences and Engineering (FTSE) and the Australasian Institute of Mining and Metallurgy (FAusIMM). Dr. Guthrie has qualifications in geology, environment, law and business management, including a PhD in Geology.
공지 • Dec 23+ 2 more updatesOrica Limited, Annual General Meeting, Feb 13, 2023Orica Limited, Annual General Meeting, Feb 13, 2023.
Reported Earnings • Nov 10Full year 2022 earnings released: EPS: AU$0.35 (vs AU$0.46 loss in FY 2021)Full year 2022 results: EPS: AU$0.35 (up from AU$0.46 loss in FY 2021). Revenue: AU$7.14b (up 36% from FY 2021). Net income: AU$144.7m (up AU$333.1m from FY 2021). Profit margin: 2.0% (up from net loss in FY 2021). Revenue is forecast to grow 2.3% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to remain flat. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 74 percentage points per year, which is a significant difference in performance.
Upcoming Dividend • May 24Upcoming dividend of AU$0.13 per shareEligible shareholders must have bought the stock before 31 May 2022. Payment date: 08 July 2022. The company is not currently making a profit and is not cash flow positive. Trailing yield: 1.5%. Lower than top quartile of German dividend payers (4.2%). Lower than average of industry peers (5.1%).
Reported Earnings • May 13First half 2022 earnings releasedFirst half 2022 results: Revenue: (down 100% from 1H 2021). Net income: (down AU$76.7m from profit in 1H 2021). Profit margin: (down from 2.9% in 1H 2021). Over the next year, revenue is forecast to grow 7.4%, compared to a 6.4% growth forecast for the industry in Germany.
Recent Insider Transactions • Nov 17Independent Non-Executive Director recently bought €161k worth of stockOn the 15th of November, Boon Foo bought around 16k shares on-market at roughly €10.06 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €380k more in shares than they have sold in the last 12 months.
Reported Earnings • Nov 12Full year 2021 earnings releasedThe company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2021 results: Revenue: AU$5.25b (down 6.7% from FY 2020). Net loss: AU$188.4m (down 212% from profit in FY 2020).
Valuation Update With 7 Day Price Move • Oct 02Investor sentiment improved over the past weekAfter last week's 17% share price gain to €8.75, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 11x in the Chemicals industry in Germany. Total loss to shareholders of 8.9% over the past three years.
Recent Insider Transactions • Oct 02Independent Non-Executive Director recently bought €85k worth of stockOn the 30th of September, Denise Gibson bought around 10k shares on-market at roughly €8.55 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €219k more in shares than they have sold in the last 12 months.
Upcoming Dividend • May 24Upcoming dividend of AU$0.075 per shareEligible shareholders must have bought the stock before 31 May 2021. Payment date: 09 July 2021. Trailing yield: 1.8%. Lower than top quartile of German dividend payers (3.2%). Lower than average of industry peers (3.6%).
Reported Earnings • May 14First half 2021 earnings released: EPS AU$0.19 (vs AU$0.43 in 1H 2020)The company reported a poor first half result with weaker earnings, revenues and profit margins. First half 2021 results: Revenue: AU$2.64b (down 8.7% from 1H 2020). Net income: AU$76.7m (down 54% from 1H 2020). Profit margin: 2.9% (down from 5.7% in 1H 2020). Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.
Executive Departure • Apr 09MD, CEO & Executive Director Alberto Zuleta has left the companyOn the 1st of April, Alberto Zuleta, was replaced as CEO by Sanjeev Gandhi. As of December 2020, Alberto personally held 268.40k shares (€2.6m worth at the time). A total of 2 executives have left over the last 12 months.
Valuation Update With 7 Day Price Move • Mar 02Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to AU$8.10, the stock is trading at a trailing P/E ratio of 29.4x, down from the previous P/E ratio of 35.7x. This compares to an average P/E of 23x in the Chemicals industry in Germany. Total return to shareholders over the past three years is a loss of 23%.
Is New 90 Day High Low • Feb 28New 90-day low: €8.30The company is down 20% from its price of €10.40 on 27 November 2020. The German market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €16.52 per share.
Recent Insider Transactions • Jan 14MD, CEO & Executive Director recently bought €83k worth of stockOn the 14th of January, Alberto Zuleta bought around 7k shares on-market at roughly €12.01 per share. This was the largest purchase by an insider in the last 3 months. Alberto has been a buyer over the last 12 months, purchasing a net total of €131k worth in shares.
Reported Earnings • Nov 22Full year 2020 earnings released: EPS AU$0.42The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: AU$5.63b (down 4.5% from FY 2019). Net income: AU$168.3m (down 31% from FY 2019). Profit margin: 3.0% (down from 4.2% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Analyst Estimate Surprise Post Earnings • Nov 22Revenue misses expectationsRevenue missed analyst estimates by 1.0%. Over the next year, revenue is forecast to grow 2.9%, compared to a 3.7% growth forecast for the Chemicals industry in Germany.
Is New 90 Day High Low • Nov 02New 90-day low: €9.05The company is down 12% from its price of €10.30 on 04 August 2020. The German market is down 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €17.54 per share.
Is New 90 Day High Low • Sep 23New 90-day low: €9.45The company is down 4.0% from its price of €9.80 on 25 June 2020. The German market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €14.46 per share.